Skip to main content

Table 4 Influence of vaccination route, post hoc explorative analysis

From: Clinical outcomes of active specific immunotherapy in advanced colorectal cancer and suspected minimal residual colorectal cancer: a meta-analysis and system review

vaccine clinical benefit rate
s.c 73/215(34.0%)
i.m 16/80(20.0%)
i.d 31/120(25.0%)
i.v 15/76(19.7%)